Calcipotriol/Betamethasone Dipropionate Cutaneous Foam Treatment for Psoriasis in Patients With BSA 5–15% and PGA ≥ 3: Post-Hoc Analysis From Three Randomized Controlled Trials
Crossref DOI link: https://doi.org/10.1007/s13555-020-00419-2
Published Online: 2020-08-12
Published Print: 2020-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Iversen, Lars
Kurvits, Merle
Snel-Prentø, Anja Marieke
Menter, Alan
Funding for this research was provided by:
LEO Pharma
Text and Data Mining valid from 2020-08-12
Version of Record valid from 2020-08-12
Article History
Received: 15 May 2020
First Online: 12 August 2020